Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹2,892 Cr
down ₹142 Cr vs Feb 2026
- Stocks held
- 30
- unchanged
- Top 10 weight
- 66.4%
- of the portfolio in its ten largest
- Cash & debt
- 1.5%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 5, trimmed 26
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In March 2026 it disclosed 30 stocks worth ₹2,892 Cr, down ₹142 Cr from Feb 2026. Its largest positions were IPCA Laboratories Limited (9.4%), Sun Pharmaceutical Industries Limited (9.3%), Cipla Limited (7.7%); the ten largest together made up 66.4% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 64.0% of its equity. Cash and debt stood at 1.5%. Compared with Feb 2026 the fund entered 0 new stocks and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
93%
Top-10 weight is higher than 93% of peers
Breadth
13%
Holds more stocks than 13% of peers
Cash
22%
Holds more cash than 22% of peers
Holdings in March 2026
Download CSVEvery line the fund disclosed, with the change against Feb 2026. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 9.39%
- Δ weight
- up 0.84 pts
- Value
- ₹272 Cr
- Δ value
- up ₹12.3 Cr
- Status
- Added
- Weight
- 9.33%
- Δ weight
- up 0.54 pts
- Value
- ₹270 Cr
- Δ value
- up ₹3.1 Cr
- Status
- Added
- Weight
- 7.68%
- Δ weight
- down 0.38 pts
- Value
- ₹222 Cr
- Δ value
- down ₹22.5 Cr
- Status
- Trimmed
- Weight
- 7.58%
- Δ weight
- down 0.11 pts
- Value
- ₹219 Cr
- Δ value
- down ₹14.2 Cr
- Status
- Trimmed
- Weight
- 6.47%
- Δ weight
- up <0.01 pts
- Value
- ₹187 Cr
- Δ value
- down ₹9 Cr
- Status
- Trimmed
- Weight
- 6.29%
- Δ weight
- down 0.21 pts
- Value
- ₹182 Cr
- Δ value
- down ₹15.2 Cr
- Status
- Trimmed
- Weight
- 6.02%
- Δ weight
- up 0.13 pts
- Value
- ₹174 Cr
- Δ value
- down ₹4.7 Cr
- Status
- Trimmed
- Weight
- 5.40%
- Δ weight
- down 0.13 pts
- Value
- ₹156 Cr
- Δ value
- down ₹11.6 Cr
- Status
- Trimmed
- Weight
- 5.00%
- Δ weight
- down 0.03 pts
- Value
- ₹144 Cr
- Δ value
- down ₹7.8 Cr
- Status
- Trimmed
- Weight
- 3.28%
- Δ weight
- down 0.07 pts
- Value
- ₹94.7 Cr
- Δ value
- down ₹6.8 Cr
- Status
- Trimmed
- Weight
- 3.28%
- Δ weight
- down 0.07 pts
- Value
- ₹94.7 Cr
- Δ value
- down ₹6.9 Cr
- Status
- Trimmed
- Weight
- 3.10%
- Δ weight
- up 0.06 pts
- Value
- ₹89.6 Cr
- Δ value
- down ₹2.5 Cr
- Status
- Trimmed
- Weight
- 2.87%
- Δ weight
- down 0.01 pts
- Value
- ₹83 Cr
- Δ value
- down ₹4.4 Cr
- Status
- Trimmed
- Weight
- 2.83%
- Δ weight
- down <0.01 pts
- Value
- ₹81.9 Cr
- Δ value
- down ₹4.1 Cr
- Status
- Trimmed
- Weight
- 2.79%
- Δ weight
- down 0.31 pts
- Value
- ₹80.6 Cr
- Δ value
- down ₹13.4 Cr
- Status
- Trimmed
- Weight
- 2.64%
- Δ weight
- up 0.07 pts
- Value
- ₹76.4 Cr
- Δ value
- down ₹1.6 Cr
- Status
- Trimmed
- Weight
- 2.14%
- Δ weight
- up 0.28 pts
- Value
- ₹61.9 Cr
- Δ value
- up ₹5.4 Cr
- Status
- Added
- Weight
- 1.83%
- Δ weight
- down 0.32 pts
- Value
- ₹53 Cr
- Δ value
- down ₹12.4 Cr
- Status
- Trimmed
- Weight
- 1.75%
- Δ weight
- down 0.25 pts
- Value
- ₹50.6 Cr
- Δ value
- down ₹10 Cr
- Status
- Trimmed
- Cash, TREPS & receivables
- Weight
- 1.45%
- Δ weight
- up 0.39 pts
- Value
- ₹42 Cr
- Δ value
- up ₹9.8 Cr
- Status
- Added
- Weight
- 1.43%
- Δ weight
- down 0.09 pts
- Value
- ₹41.3 Cr
- Δ value
- down ₹4.6 Cr
- Status
- Trimmed
- Weight
- 1.11%
- Δ weight
- down 0.13 pts
- Value
- ₹32.2 Cr
- Δ value
- down ₹5.5 Cr
- Status
- Trimmed
- Weight
- 1.06%
- Δ weight
- down 0.04 pts
- Value
- ₹30.7 Cr
- Δ value
- down ₹2.7 Cr
- Status
- Trimmed
- Weight
- 0.94%
- Δ weight
- down 0.09 pts
- Value
- ₹27.2 Cr
- Δ value
- down ₹4 Cr
- Status
- Trimmed
- Global X Funds - Global X Genomics & Biotechnology ETFFund units
- Weight
- 0.88%
- Δ weight
- up <0.01 pts
- Value
- ₹25.4 Cr
- Δ value
- down ₹1.2 Cr
- Status
- Trimmed
- Weight
- 0.86%
- Δ weight
- down 0.11 pts
- Value
- ₹25 Cr
- Δ value
- down ₹4.5 Cr
- Status
- Trimmed
- Weight
- 0.68%
- Δ weight
- down 0.01 pts
- Value
- ₹19.8 Cr
- Δ value
- down ₹1.3 Cr
- Status
- Trimmed
- Weight
- 0.63%
- Δ weight
- up 0.02 pts
- Value
- ₹18.2 Cr
- Δ value
- down ₹36 L
- Status
- Trimmed
- Weight
- 0.56%
- Δ weight
- up 0.02 pts
- Value
- ₹16.1 Cr
- Δ value
- down ₹15 L
- Status
- Trimmed
- Weight
- 0.42%
- Δ weight
- up 0.03 pts
- Value
- ₹12.1 Cr
- Δ value
- up ₹18 L
- Status
- Added
- Weight
- 0.15%
- Δ weight
- down 0.02 pts
- Value
- ₹4.4 Cr
- Δ value
- down ₹96 L
- Status
- Trimmed
- Weight
- 0.15%
- Δ weight
- up 0.01 pts
- Value
- ₹4.3 Cr
- Δ value
- up ₹4 L
- Status
- Added
What changed, Feb 2026 to Mar 2026
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- IPCA Laboratories Limitedup ₹12.3 Cr (+0.84% pts)
- Emcure Pharmaceuticals Limitedup ₹5.4 Cr (+0.28% pts)
- Sun Pharmaceutical Industries Limitedup ₹3.1 Cr (+0.54% pts)
- Jupiter Life Line Hospitals Limitedup ₹18 L (+0.03% pts)
- Grail Inc ₹4 L (+0.01% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Feb 2026, the weight rose most in Pharmaceuticals & Biotechnology (+1.0 pts), and fell most in Pharmaceuticals (−0.5 pts) and Healthcare Services (−0.4 pts).
- Pharmaceuticals & Biotechnology63.1% → 64.0%+1.0 pts
- Pharmaceuticals4.3% → 3.9%−0.5 pts
- Healthcare Services19.6% → 19.3%−0.4 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Mar 2023 | Mar 2025 | Sep 2025 | Dec 2025 | Feb 2026 | Mar 2026 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 69.9% | 66.4% | 67.7% | 64.1% | 63.1% | 64.0% |
| Healthcare Services | 15.2% | 17.2% | 17.2% | 18.7% | 19.6% | 19.3% |
| Healthcare Equipment & Supplies | 6.0% | 8.7% | 7.4% | 10.3% | 10.9% | 10.8% |
| Pharmaceuticals | 5.7% | 5.7% | 5.7% | 4.9% | 4.3% | 3.9% |
| Insurance | 2.2% | 1.5% | 1.5% | 1.5% | 1.5% | 1.5% |
| Retailing | 1.1% | 0.5% | 0.5% | 0.5% | 0.5% | 0.6% |
Allocation in Mar 2026change vs Feb 2026
- Pharmaceuticals & Biotechnology (15)64.0%▲ 1.0 pts
- Healthcare Services (7)19.3%▼ 0.4 pts
- Healthcare Equipment & Supplies (3)10.8%▼ 0.1 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Mar 2026
1.5%
▲ 0.4 pts vs Feb 2026
- Cash alone
- 1.5%
- cash and net receivables
- A year earlier
- 0.8%
- Mar 2025 · now ▲ 0.6 pts
- Last 12 months
- 0.1% – 2.2%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.